NCT04255082

Brief Summary

The purpose of this study is to assess the impact of mindfulness-based interventions on patient stress, patient-provider communication, and other measures of SDM at MDMC. There is a need to have a quantifiable measure of perceived stress and communication ability in patients. This is the first study of its kind to be conducted at MDMC. This pilot study will not only benefit the patients but also contribute to the medical community's understanding of treating the whole patient through mindfulness and shared decision making. 2.1. Study Objectives 2.1.1. Primary Objective To assess the impact of mindfulness-based interventions on inpatients and outpatients stress, patient-provider communication, and other measures of SDM at MDMC. 2.1.2. Secondary Objectives To evaluate the feasibility of such a study in the patient population.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
56

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 15, 2018

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

April 3, 2019

Completed
10 months until next milestone

First Posted

Study publicly available on registry

February 5, 2020

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 20, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 20, 2022

Completed
Last Updated

March 23, 2026

Status Verified

September 1, 2022

Enrollment Period

3.9 years

First QC Date

April 3, 2019

Last Update Submit

March 19, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Baseline and post-intervention perception of stress & anxiety by answering survey questions

    Effectiveness of the mindfulness-based intervention which will be assessed by survey questions: Baseline and post-intervention perception of stress and anxiety t of stress on communication Emotional/Brain state Level of SDM during a pivotal visit with provider e.g. treatment planning visit (for outpatients only) The Emotional Distress-Anxiety (PROMIS, 2016).

    6/1/2018 and 12/31/2020

Secondary Outcomes (1)

  • Feasibility of a study in the patient population and setting by any difficulties faced during the study phase

    6/1/2018 and 12/31/2020

Interventions

Effectiveness of the mindfulness-based intervention which will be assessed by: Baseline and post-intervention perception of stress and anxiety Impact of stress on communication Emotional/Brain state Level of SDM during a pivotal visit with provider e.g. treatment planning visit (for outpatients only) The Emotional Distress-Anxiety (PROMIS, 2016), Communication Short Form (Cella, PROMIS, 2013), Emotional/Brain State Question (Mellin, 2017) and The Shared Decision Making dyadic OPTION scale (Melbourne, 2016) will be used to evaluate these outcomes. Feasibility of such a study in the patient population and setting. This will be measured by the barriers encountered and the ability to successfully carry out the study.

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients at MDMC, The Liver Institute, and Texas Oncology between 6/1/2018 and 12/31/2020.

You may qualify if:

  • Age 18 years or older
  • Inpatients and outpatients receiving treatment at MDMC, the Liver Institute, or Texas Oncology
  • Provided written informed consent

You may not qualify if:

  • Below 18 years of age

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Liver Institute at Methodist Dallas Medical Center

Irving, Texas, 75603, United States

Location

MeSH Terms

Conditions

Liver Diseases

Condition Hierarchy (Ancestors)

Digestive System Diseases

Study Officials

  • Parvez Mantry, M.D.

    Methodist Health System

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
7 Days
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 3, 2019

First Posted

February 5, 2020

Study Start

August 15, 2018

Primary Completion

July 20, 2022

Study Completion

July 20, 2022

Last Updated

March 23, 2026

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will not share

Locations